Understanding Which of the following is used as first line treatment for a severe cellular rejection episode?
•
4 min read
Approximately 10-20% of kidney transplant recipients experience acute rejection in the first year. Knowing which of the following is used as first line treatment for a severe cellular rejection episode is critical for managing this immune response and protecting the transplanted organ.